Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indications for hyperprolactinemia therapy.

D Olive1

  • 1Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

The Journal of Reproductive Medicine
|January 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy.

Seminars in immunopathology·2022
Same author

Revue des maladies respiratoires actualites·2020
Same author

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects.

Journal of immunology research·2016
Same author

Multi-parametric cytometry from a complex cellular sample: Improvements and limits of manual versus computational-based interactive analyses.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2016
Same author

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice.

International journal of obesity (2005)·2015
Same journal

Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic.

The Journal of reproductive medicine·2022
Same journal

Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report.

The Journal of reproductive medicine·2018
Same journal

Isolated Recurrent Hematotrachelos After Abdominal Myomectomy A Case Report.

The Journal of reproductive medicine·2018
Same journal

Live Birth from Electively Cryopreserved Oocytes: A Feasible Option for Couples Opposed to Embryo Cryopreservation A Case Report.

The Journal of reproductive medicine·2018
Same journal

Prevalence and Risk Factors of Ejaculation Failure on the Day of Operation Among Chinese Males Undergoing Assisted Reproductive Technique Treatments.

The Journal of reproductive medicine·2018
Same journal

Efficacy and Safety of Perioperative Use of Epinephrine for Laparoscopic Myomectomy in Infertile Women with Symptomatic Solitary Intramural Uterine Fibroids A Randomized Clinical Trial.

The Journal of reproductive medicine·2018
See all related articles

Hyperprolactinemia diagnosis requires careful verification of underlying causes before treatment. Dopamine agonists are the primary medical therapy for symptomatic patients, addressing infertility, visual defects, and bone density loss.

Area of Science:

  • Endocrinology
  • Reproductive Medicine
  • Neurology

Background:

  • Hyperprolactinemia is an elevated prolactin level, often indicating an underlying condition.
  • It can manifest with various symptoms affecting both men and women.
  • Accurate diagnosis is crucial before commencing treatment.

Purpose of the Study:

  • To emphasize the importance of verifying hyperprolactinemia diagnosis.
  • To outline the indications for initiating treatment.
  • To highlight the role of dopamine agonists in management.

Main Methods:

  • Review of diagnostic criteria for hyperprolactinemia.
  • Assessment of clinical indications for therapeutic intervention.
  • Evaluation of medical treatment options, primarily dopamine agonists.

Related Experiment Videos

Main Results:

  • Hyperprolactinemia is a laboratory finding reflecting an underlying pathology.
  • Treatment indications include significant symptoms (infertility, ovulatory dysfunction, galactorrhea, gynecomastia), physical signs (visual field defects), and abnormal findings (pituitary mass, osteopenia).
  • Dopamine agonists are the mainstay of medical treatment.

Conclusions:

  • Thorough investigation to identify or exclude all potential causes of hyperprolactinemia is essential prior to therapy.
  • Medical management with dopamine agonists is effective for indicated cases.
  • Treatment decisions should be guided by symptoms, signs, and specific test results.